Trial Profile
A randomized double blind, placebo controlled trial to evaluate the effect of ebselen on tasks of emotional processing in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Oct 2015
Price :
$35
*
At a glance
- Drugs Ebselen (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 26 Oct 2015 New trial record
- 01 Sep 2015 Results of this and other phase I trial (see profile 2621801), presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.